SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

AstraZeneca Secures US and EU Approvals for Klygefa

AstraZeneca’s rare disease unit secured US and EU approvals for Klygefa for myasthenia gravis.

AZN

Related stories